结肠癌-杰傲病理
联系我们 投诉建议 非医学专业人员
Colon Cancer

According to the American Cancer Society, men have a 1 in 21 chance of developing colon cancer in their lifetime. For women, the risk is slightly lower.

GoPath has developed several molecular tests to diagnose colon cancer and to detect genetic mutations that affect how the progresses and responds to treatment. This means that our tests yield results that help your doctor create a treatment plan that is tailor-made to best treat your particular type of cancer. 

These tests include:

          •     Colon Profile - Examines associated biomarkers: KRAS, BRAF, NRAS, PIK3CA
          •     OncoDefenderTM CRC - Predicts risk of recurrence for early stage colorectal cancer
          •     LynchNowTM  - Hereditary testing for Lynch syndrome-related cancers
          •     Colon Biopsy